Ashkon Software







 

NVDQ - T-Rex 2X Inverse NVIDIA Daily Target ETF

Expense Ratio: 1.05%

NVDQ ETF Stock Chart

NVDQ Profile

T-Rex 2X Inverse NVIDIA Daily Target ETF logo

Novadaq Technologies Inc., trading under the ticker symbol NVDQ, was a medical technology company that developed and marketed imaging solutions for use in surgeries and diagnostic procedures. The company was headquartered in Mississauga, Ontario, Canada.

Novadaq Technologies was founded in 2000 and quickly established itself as a leader in the field of fluorescence imaging. The company's products and solutions included SPY Elite fluorescence imaging system, LUNA fluorescence angiography system, and PINPOINT endoscopic fluorescence imaging system, among others.

In 2017, Stryker Corporation acquired Novadaq Technologies for approximately $701 million, and the company was delisted from the Toronto Stock Exchange and NASDAQ stock exchange.

Prior to its acquisition, as of its most recent financial filings, Novadaq Technologies had revenues of approximately $70 million and employed over 300 professionals across its various operations worldwide. The company faced competition from other medical technology companies operating in the imaging and surgical products industries.

Investors who held NVDQ stock should have received compensation from the acquisition. Investors who are interested in the medical technology industry may want to research other publicly traded companies in the sector, evaluate their financial performance, competitive position, and growth


 

Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer